Coffee protects against liver cancer while alcohol is linked with numerous cancers
Alcohol consumption is a major risk factor for several cancers including head & neck (mouth, pharynx, larynx), oesophageal and bowel cancer - as well as the more widely known links to breast and liver cancer - according to a new study funded by World Cancer Research Fund (WCRF)(1), and published this week in Nature Communications. The study also found increased coffee consumption was associated with a lower risk of developing liver cancer and basal cell carcinoma of the skin. (Source: World Pharma News)
Source: World Pharma News - August 4, 2021 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
FDA Grants Orphan Drug Designation to Novel Mesothelioma Treatment
The U.S. Food and Drug Administration has granted orphan drug designation to ONCOFID-P for the treatment of malignant pleural mesothelioma, a step toward another potential therapy option for patients.
ONCOFID-P is an innovative drug conjugate already in advanced clinical development for the treatment of invasive bladder cancer. The mesothelioma designation is based on preclinical data showing high antitumor activity in laboratory and mice models.
Fidia Farmaceutici, a multinational research company based in Italy, announced the latest FDA designation, which is designed to encourage the development of novel drugs, par...
Source: Asbestos and Mesothelioma News - July 28, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news
Alcohol caused 740,000 cancer cases globally last year – study
Researchers behind estimate say more needs to be done to raise public awareness of linkAlcohol is estimated to have caused more than 740,000 cancer cases around the world last year, and experts say more needs to be done to highlight the link.There is strong evidence that alcohol consumption can cause various cancers including those of the breast, liver, colon, rectum, oropharynx, larynx and oesophagus. Research suggests that evenlow levels of drinking can increase the risk.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - July 13, 2021 Category: Science Authors: Nicola Davis Science correspondent Tags: Alcohol Cancer Medical research Breast cancer Health Science Society Source Type: news
AI software may help spot early signs of oesophageal cancer
Software in use at an NHS trust could prove a breakthrough in diagnosing one of the deadliest forms of cancerOne of the NHS ’s leading hospital trusts has begun using artificial intelligence to help detect cancer in the gullet, whichkills 8,000 Britons a year. It is hoped the technology will increase the number of cases of cancer in the oesophagus that doctors spot.Oesophageal cancer is one of the deadliest forms of cancer. It is hard to detect, particularly in its early stages, and many people who get it die soon after their diagnosis. Fewer than one in five of those diagnosed are still alive five years later.Continue r...
Source: Guardian Unlimited Science - July 1, 2021 Category: Science Authors: Denis Campbell Health policy editor Tags: Cancer NHS Artificial intelligence (AI) Cancer research Medical research Health Science Society Technology UK news Source Type: news
Blood test for personalized cancer treatment
(Flinders University) A blood test to help guide the treatment of esophageal, stomach and bowel cancers will be evaluated in a new Flinders University trial set to get underway. The trial is thanks to a federal government grant of almost $2 million announced yesterday, with Flinders University awarded funding for three projects, totaling $5.8 million. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 1, 2021 Category: Cancer & Oncology Source Type: news
‘Sponge on a string’ test will help pinpoint gullet cancer
UK trials begin for test that detects risk of oesophageal diseaseTrials of a new weapon in the battle against cancer are to be launched across Britain next month. The cytosponge – a sponge on a string – is to be used to pinpoint individuals at risk of developing oesophageal cancer.The aim is to tackle one of Britain ’s most pernicious illnesses. Oesophageal cancer is often diagnosed late in its development when it is difficult to treat. It is the sixth most common cause of cancer deaths in the UK with only 15% of patients surviving five years after diagnosis and is more common in older people.Continue reading... (Sou...
Source: Guardian Unlimited Science - June 27, 2021 Category: Science Authors: Robin McKie Tags: Cancer research Medical research Science UK news Source Type: news
Investigating a better treatment sequence for esophageal cancer
(University of Colorado Anschutz Medical Campus) University of Colorado Cancer Center member Martin McCarter, MD, is investigating whether a new treatment sequence will result in better outcome for patients with esophageal cancer. As they await the results of a group of clinical trials, McCarter and other CU researchers looked at data from the National Cancer Database to identify other patients who have undergone the new sequence, and what the outcomes for those patients were. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 22, 2021 Category: Cancer & Oncology Source Type: news
Running in the blood: Blood lipids are linked to cancer, but depending on family history
(Cactus Communications) Several studies have associated blood lipids with different types of cancer like that of the food pipe or 'esophagus,' but much remains to be understood, to apply this knowledge clinically. A group of Chinese scientists has successfully advanced this line of research, by identifying the role of family history in modifying the association between blood lipids and risk of developing esophageal malignant lesions, according to a new study published in Chinese Medical Journal. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 21, 2021 Category: Cancer & Oncology Source Type: news
Esophageal Cancer Responsive to Immune Cell Therapy + Nivolumab Esophageal Cancer Responsive to Immune Cell Therapy + Nivolumab
This report suggests that a combination of adoptive immune cell therapy and an immune checkpoint inhibitor might be a possible treatment strategy for advanced esophageal cancer.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 17, 2021 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news
FDA approves nivolumab in combination with chemotherapy for metastatic gastric cancer and esophageal adenocarcinoma
Hematology / Oncology (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 10, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Immunotherapy Likely New Standard in Advanced Esophageal Cancer Immunotherapy Likely New Standard in Advanced Esophageal Cancer
Nivolumab with chemotherapy or nivolumab with ipilimumab improved overall survival as compared with standard chemotherapy in advanced ESCC.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 3, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
FDA OKs Nivolumab After Surgery for Esophageal or GEJ Cancer FDA OKs Nivolumab After Surgery for Esophageal or GEJ Cancer
The adjuvant use of nivolumab has been described as practice-changing in patients with resected esophageal or gastroesophageal junction cancer who have received chemoradiotherapy before surgery.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 20, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news
FDA approves nivolumab for resected esophageal or GEJ cancer
Hematology / Oncology News Burst (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - May 20, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news
As MRI strength increases, so do concerns about magnet safety
As the push toward stronger and faster MRI scanners continues, so does concer...Read more on AuntMinnie.comRelated Reading:
Tips and tricks for finding lithium batteries in the esophagus on MRI
Bedside point-of-care MRI appears convenient and accurate
AI, radiomics can predict cancer in lesions found on breast MRI
Ensuring patient privacy is key in MRI research projects
7T MRI shows promise for sports imaging of injured athletes (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 20, 2021 Category: Radiology Source Type: news
U.S. FDA Approves Opdivo (nivolumab) as Adjuvant Treatment of Completely Resected Esophageal or Gastroesophageal Junction Cancer in Patients who have Received Neoadjuvant Chemoradiotherapy
PRINCETON, N.J.--(BUSINESS WIRE) May 20, 2021 -- Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has approved Opdivo® (nivolumab, injection for intravenous use) for the adjuvant treatment of... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - May 20, 2021 Category: Drugs & Pharmacology Source Type: news
